November 20, 2014 NJ could become 3rd state to legalize right to die New Jersey may become the third state to legalize physician-assisted suicide after a state lawmaker proposed a bill to grant doctors the right to prescribe lethal doses of drugs to terminally ill patients
November 20, 2014 Bagel head trend on the rise in Japan A new trend in body art has emerged in Japan – known as the “bagel head." The bizarre look is created by injecting saline into the forehead until it swells up, and then pressing in the center of the swollen area with a thumb.
November 20, 2014 Toxin leak at New York school sparks worries A PCB leak at a New York school has parents and local leaders outraged
November 20, 2014 Study challenges abdominal artery screenings A Medicare program to screen certain beneficiaries for potentially dangerous bulges on the main abdominal artery has had only limited impact, according to a new study
November 20, 2014 Study on Monsanto GM corn concerns draws skepticism In a study that prompted sharp criticism from other experts, French scientists said on Wednesday that rats fed on Monsanto's genetically modified corn or exposed to its top-selling weedkiller suffered tumors and multiple organ damage
November 20, 2014 FDA issues warning for over-the-counter diarrhea drug The Food and Drug Administration is warning consumers not to use an over-the-counter drug called Intestinomicina because the anti-diarrhea treatment contains a drug linked to life-threatening injuries
November 20, 2014 FDA warns of burns from muscle and joint pain busters Over-the-counter muscle and joint pain relievers may cause chemical burns in rare cases, U.S. health regulators warned
November 20, 2014 Drug firm to test cannabis chemical in epilepsy A British drug company aims to test a compound found in cannabis as a treatment for epilepsy, following a promising study using the chemical in rats and mice
November 20, 2014 Sanofi multiple sclerosis pill gets US approval Sanofi SA has won U.S. approval for its multiple sclerosis pill Aubagio. The drug has been shown to be less effective than some rivals but has milder side effects and analysts say it could find favor among newly diagnosed patients
November 20, 2014 US revoking 2 CVS stores' controlled substance licenses The U.S. Drug Enforcement Administration is revoking the controlled substance licenses of two CVS Caremark Corp drugstores in Florida as part of a government crackdown on potentially addictive painkillers, especially oxycodone